A new deal between UnitedHealthcare and device maker Medtronic means fewer options for UnitedHealth customers who need insulin pumps to treat Type 1 diabetes.
Most customers’ choices will now be limited to one of three pumps, unless they have a medical need for another option or are willing to pay more for another brand.
For more on the patient reaction to this change and whether other insurers will follow with similar limits on devices, click on the link below:
John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.